Dipexium Pharmaceuticals, Inc. 4
4 · Dipexium Pharmaceuticals, Inc. · Filed Jan 29, 2015
Insider Transaction Report
Form 4
Shawah Robert G.
Chief Accounting Officer
Transactions
- Award
Options
2015-01-05$11.35/sh+35,000$397,250→ 120.379 totalExercise: $11.35Exp: 2025-01-05→ Common stock, $0.001 par value per share (35,000 underlying)
Footnotes (1)
- [F1]Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period, subject to accelerated vesting on a change of control.